Enter your keywords
HOME
About Us
NEWSLETTER
To search AlzRisk, use the "Keyword" search on the
AlzRisk search page
.
NEWS
All News
Conference Coverage
Series
WEBINARS
All Webinars
Databases
AlzBiomarker
AlzPedia
AlzRisk
Antibodies
Genetics
AlzGene
HEX
Mutations
Protocols
Research Models
Therapeutics
PAPERS
All Papers
Papers of the Week
Milestone
Alzforum Recommends
PROFESSIONAL RESOURCES
Conference Calendar
Grants
Jobs
Member Directory
ABOUT AD
AD Overview
Early-Onset Familial
The HBO Alzheimer's Project
Supported Browsers
MY ALZFORUM
My AlzForum Home
View Library
View Notifications
Set Notifications
Edit Profile
AlzRisk Paper Detail
Risk Factors
Alcohol
B Vitamins
Blood Pressure
Cognitive Activity
Diabetes Mellitus
Dietary Pattern
Head injury
Homocysteine
Hormone Therapy
Inflammatory Biomarkers
Non-Steroidal Anti-Inflammatory Drugs
Nutritional Antioxidants
Obesity
Physical Activity
Statin use
Reference:
Morris, 2002
Cohort:
Chicago Health and Aging Project
Risk Factor:
Nutritional Antioxidants
Exposure Detail
Supplement use reported via food frequency questionnaire.
"Study participants completed a self-administered food frequency questionnaire …. The CHAP food frequency questionnaire, a modified version of the Harvard food frequency questionnaire,
31,32
was used to measure usual intake of 139 food items throughout the previous year, as well as the use of vitamin supplements. Nutrient intakes were computed by multiplying the nutrient contents of food items by frequency of consumption and summing across all items. Nutrient levels were adjusted for total energy intake separately for men and women by using the regression residual method.
33
"
Age Detail
Age at start of follow-up is the age at enrollment. Vitamin E intake assessed 1.7 years later, which was 2.3 years prior to dementia assessment.
Screening and Diagnosis Detail
AD Diagnosis:
NINCDS ADRDA
National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association Criteria (McKhann 1984)
Other
Other diagnostic criterion:
Although investigators used the NINCDS-ADRDA criteria as the basis for identifying AD cases, they also identified cases as "persons who met the criteria but had another coexisting condition that was thought to contribute to dementia."
“The 2 1⁄2-hour clinical evaluations were conducted in participants’ homes by a team consisting of a neurologist, nurse practitioner, and neuropsychological technician. The evaluations included a medical history, a structured neurological examination, neuropsychological testing (using the tests of Consortium Established for Research on Alzheimer’s Disease, CERAD
34
), informant interviews, and laboratory testing. Magnetic resonance imaging (MRI) was performed when dementia was evident and stroke occurrence was clinically uncertain (9 persons). A board-certified neurologist blinded to the dietary assessment data reviewed all clinical evaluation data before making clinical diagnoses of neurological diseases. Diagnoses of AD were made according to criteria of the National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer’s Disease and Related Dementia Association (NINCDS ADRDA),
35
except that we did not exclude as cases persons who met the criteria but had another coexisting condition that was thought to contribute to dementia. Eleven persons with incident dementia caused by a condition other than AD were analyzed as noncases.”
Covariates & Analysis Detail
Analysis Type:
Logistic regression
Sample design accounted for by use of weights in analysis.
AD Covariates:
A
age
E
education
G
gender
APOE4
APOE e4 genotype
VITED
dietary vitamin E
O
other
RE
race/ethnicity
SS
stratified sampling
Also adjusted for period of observation and interaction between race and APOE e4 genotype.